Article
Targeting Chronic Lymphocytic Leukemia With DNA Nanoparticles
2013-11-15
Abstract excerpt
Abstract A significant challenge in many areas of cancer research and treatment is the lack of cancer cell-specific binding agents. In Chronic Lymphocytic Leukemia (CLL), numerous genetic and molecular markers are used to divide patients into prognostic categories but clearly distinguished etiological or biological subtypes remain elusive. The current targeted treatments for CLL include monoclonal antibodies: alem...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 52d2511c-4359-5628-95cb-92769c54ed4c
- DOI
- 10.1182/blood.v122.21.1623.1623
